Evidence map›Paper›PMID 40498231›Full record

ArticleMolecular diversity2026

Advancing the development of deep learning and machine learning models for oral drugs through diverse descriptor classes: a focus on pharmacokinetic parameters (Vdss and PPB).

Rakesh Bantu, Samiron Phukan, Simon Haydar

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rakesh BantuIntegrated Drug Discovery, Aragen Lifesciences Ltd, Hyderabad, 500076, India.
Samiron PhukanIntegrated Drug Discovery, Aragen Lifesciences Ltd, Hyderabad, 500076, India. samiron.phukan@aragen.com.ORCID http://orcid.org/0000-0002-5009-2340
Simon HaydarIntegrated Drug Discovery, Aragen Lifesciences Ltd, Hyderabad, 500076, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we report a predictive deep learning (DL) and machine learning (ML) model for pharmacokinetics (PK) parameters such as volume of distribution (Vdss) and plasma protein Binding (PPB). Using DL & ML algorithms our study provides a deeper and novel insights into the role of molecular descriptors in determining the PK parameters such as Vdss and PPB. FDA approved drugs with oral route of administration and having reported PK parameters were taken as the dataset. This was used for establishment of the foundational datasets followed by computation of different molecular descriptor classes. Feature engineering by Boruta algorithm exhibited significant increase in accuracy of the models. Features identified by Boruta algorithm, were trained for different models separately for both Vdss and PPB. The highest predictive scores amongst the models were achieved in gradient boosting (GB) and Stacking Classifier with 80% and 78% for Vdss. In the case of PPB, random forest and GB algorithm predicted the highest scores of 73% and 71%, respectively, in comparison to all other algorithms. In summary we report here appropriate ML algorithms like Stacking Classifier-by utilizing an unreported feature engineering algorithm -to predict Vdss and PPB individually considering over 67 descriptors each with ≥ 80% accuracy and 73% accuracy, respectively. Additionally, we developed models based on the shared descriptors between Vdss and PPB. Quantum chemical descriptors like MLFERs (MLFER_BH, MLFER_BO & MLFER_E) and topological descriptors like piPC5, piPC6, piPC9 & TpiPC identified as the common drivers of the functional activity of Vdss and PPB together.

Indexed as

Deep LearningMachine LearningPharmacokineticsAdministration, OralAlgorithmsBlood ProteinsHumansPharmaceutical PreparationsProtein BindingBlood ProteinsPharmaceutical PreparationsCheminformaticsDeep learning (DL)Drug metabolism and pharmacokinetics (DMPK)Machine learning (ML)Molecular descriptorsPlasma protein bindingVolume of distribution

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.